pilot study of second line therapy for AAA Acquired Aplastic Anemia with antithymocyte globulin, cyclosporin and etanercept - ND pilot study of second line therapy for AAA Acquired Aplastic Anemia with antithymocyte globulin, cyc ...
pilot study of second line therapy for AAA Acquired Aplastic Anemia with antithymocyte globulin, cyclosporin and etanercept - ND pilot study of second line therapy for AAA Acquired Aplastic Anemia with antithymocyte globulin, cyc ...
A pilot multicentric study for the use of the anti-TNF alfa in patients with: 1) Fanconi Anemia with marrow failure with no bone marrow compatible donor 2) In patients with acquired aplastic anemia failing immunosuppression and with no bone marrow donor A pilot multicentric study for the use of the anti-TNF alfa in patients with: 1) Fanconi Anemia with ...
A pilot multicentric study for the use of the anti-TNF alfa in patients with: 1) Fanconi Anemia with marrow failure with no bone marrow compatible donor 2) In patients with acquired aplastic anemia failing immunosuppression and with no bone marrow donor A pilot multicentric study for the use of the anti-TNF alfa in patients with: 1) Fanconi Anemia with ...
Marrow failure in patients refractary/non eligible to conventional treatments;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15] Marrow failure in patients refractary/non eligible to conventional treatments;Therapeutic area: Dise ...